Method of treating neurodegenerative disease

Details for Australian Patent Application No. 2010210023 (hide)

Owner Mayo Foundation for Medical Education and Research Alnylam Pharmaceuticals, Inc.

Inventors Bumcrot, David; Farrer, Matthew J.; Maraganore, Demetrius; Vornlocher, Hans-Peter

Agent Griffith Hack

Pub. Number AU-B-2010210023

Parent 2004255557

Filing date 9 August 2010

Wipo publication date 2 September 2010

Acceptance publication date 22 December 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

26 August 2010 Complete Application Filed

2 September 2010 Application Open to Public Inspection

  Published as AU-B-2010210023

22 December 2011 Application Accepted

  Published as AU-B-2010210023

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210024-Dust collector control system

2010210022-Stent graft having a marker and a reinforcing and marker ring